Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
May 26, 2017
Finance
Europe’s bellwether challenge
...Aisling Capital , Brace Pharma Capital , Advent Life Sciences, Novartis Venture Fund, Sunstone Capital,
Merifin Capital
...
Read More
BioCentury
|
Jun 27, 2016
Finance
Funding antifungals
...Brace Pharma Capital joined existing investors Advent Life Sciences, Novartis Venture Fund, Sunstone Capital and
Merifin Capital
...
Read More
BioCentury
|
Jun 27, 2016
Financial News
F2G completes venture financing
...A/S ; Aisling Capital ; Brace Pharma Capital; Advent Life Sciences; Novartis Venture Fund; Sunstone;
Merifin Capital
WIR...
Read More
BioCentury
|
Jun 21, 2016
Financial News
F2G raises $60M for antifungals
...also participated, as did existing investors Advent Life Sciences, Novartis Venture Fund, Sunstone Capital and
Merifin Capital
...
Read More
BioCentury
|
Oct 21, 2013
Finance
Immunotherapy top up
...MIG Funds; AT Impf; Grazia Equity; EMBL Ventures; SB Asset Management; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 10, 2012
Financial News
F2G completes venture financing
...Type: Venture financing Raised: $30 million Investors: Advent Life Sciences; Novartis Venture Funds; Sunstone Capital;
Merifin Capital
...
Read More
BioCentury
|
Sep 6, 2012
Financial News
F2G raises $30M
...another opportunity. New investors Advent Life Sciences and Novartis Bioventures joined existing investors Sunstone Capital;
Merifin Capital
...
Read More
BioCentury
|
Sep 27, 2010
Finance
Phase III top off
...Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 27, 2010
Financial News
immatics completes venture financing
...Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital AG; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 21, 2010
Financial News
dievini Hopp co-leads EUR 53.8M immatics round
...Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
Items per page:
10
1 - 10 of 13
BioCentury
|
May 26, 2017
Finance
Europe’s bellwether challenge
...Aisling Capital , Brace Pharma Capital , Advent Life Sciences, Novartis Venture Fund, Sunstone Capital,
Merifin Capital
...
Read More
BioCentury
|
Jun 27, 2016
Finance
Funding antifungals
...Brace Pharma Capital joined existing investors Advent Life Sciences, Novartis Venture Fund, Sunstone Capital and
Merifin Capital
...
Read More
BioCentury
|
Jun 27, 2016
Financial News
F2G completes venture financing
...A/S ; Aisling Capital ; Brace Pharma Capital; Advent Life Sciences; Novartis Venture Fund; Sunstone;
Merifin Capital
WIR...
Read More
BioCentury
|
Jun 21, 2016
Financial News
F2G raises $60M for antifungals
...also participated, as did existing investors Advent Life Sciences, Novartis Venture Fund, Sunstone Capital and
Merifin Capital
...
Read More
BioCentury
|
Oct 21, 2013
Finance
Immunotherapy top up
...MIG Funds; AT Impf; Grazia Equity; EMBL Ventures; SB Asset Management; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 10, 2012
Financial News
F2G completes venture financing
...Type: Venture financing Raised: $30 million Investors: Advent Life Sciences; Novartis Venture Funds; Sunstone Capital;
Merifin Capital
...
Read More
BioCentury
|
Sep 6, 2012
Financial News
F2G raises $30M
...another opportunity. New investors Advent Life Sciences and Novartis Bioventures joined existing investors Sunstone Capital;
Merifin Capital
...
Read More
BioCentury
|
Sep 27, 2010
Finance
Phase III top off
...Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 27, 2010
Financial News
immatics completes venture financing
...Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital AG; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
BioCentury
|
Sep 21, 2010
Financial News
dievini Hopp co-leads EUR 53.8M immatics round
...Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises;
Merifin Capital
...
Read More
Items per page:
10
1 - 10 of 13
Previous page
Next page